國立虎尾科技大學 |

Mechanisms of drug resistance in cancer therapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Mechanisms of drug resistance in cancer therapy/ edited by Mario Mandala, Emanuela Romano.
other author:	Mandala, Mario.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	viii, 297 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Drug resistance in cancer cells. -
Online resource:	https://doi.org/10.1007/978-3-030-10507-5
ISBN:	9783030105075

Mechanisms of drug resistance in cancer therapy
Mechanisms of drug resistance in cancer therapy[electronic resource] /edited by Mario Mandala, Emanuela Romano. - Cham :Springer International Publishing :2018. - viii, 297 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2490171-2004 ;. - Handbook of experimental pharmacology ;v.212..

1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm -- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival -- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies -- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer -- 5. Mechanisms of Drug Resistance in Melanoma -- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies -- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma -- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer -- 9. Targeting DNA repair -- 10. Resistance to Hormonal Therapy in Prostate Cancer -- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors -- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia -- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia -- 14. Mechanisms of Resistance in Multiple Myeloma -- 15. Cancer Evolution as the New Frontier of Precision.

A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.

ISBN: 9783030105075

Standard No.: 10.1007/978-3-030-10507-5doiSubjects--Topical Terms:

681914
Drug resistance in cancer cells.

LC Class. No.: RC271.C5 / M434 2018

Dewey Class. No.: 616.994061

Mechanisms of drug resistance in cancer therapy
LDR:02621nam a2200337 a 4500 001 930389
003 DE-He213
005 20190508172139.0
006 m d
007 cr nn 008maaau
008 190627s2018 gw s 0 eng d
020 $a 9783030105075 $q (electronic bk.)
020 $a 9783030105068 $q (paper)
024 7 $a 10.1007/978-3-030-10507-5 $2 doi
035 $a 978-3-030-10507-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5 $b M434 2018
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 616.994061 $2 23
090 $a RC271.C5 $b M486 2018
245 0 0 $a Mechanisms of drug resistance in cancer therapy $h [electronic resource] / $c edited by Mario Mandala, Emanuela Romano.
260 $a Cham : $c 2018. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 297 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.249
505 0 $a 1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm -- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival -- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies -- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer -- 5. Mechanisms of Drug Resistance in Melanoma -- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies -- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma -- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer -- 9. Targeting DNA repair -- 10. Resistance to Hormonal Therapy in Prostate Cancer -- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors -- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia -- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia -- 14. Mechanisms of Resistance in Multiple Myeloma -- 15. Cancer Evolution as the New Frontier of Precision.
520 $a A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.
650 0 $a Drug resistance in cancer cells. $3 681914
650 0 $a Cancer $x Chemotherapy. $3 645264
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Drug Resistance. $3 782695
650 2 4 $a Molecular Medicine. $3 668353
700 1 $a Mandala, Mario. $3 1211533
700 1 $a Romano, Emanuela. $3 1211534
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v v.212. $3 882814
856 4 0 $u https://doi.org/10.1007/978-3-030-10507-5
950 $a Biomedical and Life Sciences (Springer-11642)